Insmed Quarterly Cash Flow Statement
NASDAQ: INSMHealthcareBiotechnologyUSD
100.60+0.12 (+0.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insmed free cash flow
In the quarter ended Jun 30, 2026, Insmed generated -$88.8 million of operating cash flow and spent $6.3 million on capital expenditures. That left free cash flow of -$95.1 million, a free-cash-flow margin of -22.3% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Insmed cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -13.24M | -163.56M | -328.49M | -370.02M | -321.69M | -256.58M | -235.55M | -220.52M | -300.61M | -157.09M | -186.06M | -158.93M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.18M | 2.93M | 3.62M | 2.46M | 2.48M | 1.88M | 1.48M | 1.46M | 1.44M | 1.59M | 1.48M | 1.49M |
| Stock-Based Compensation | 41.25M | 45.75M | 39.04M | 31.43M | 42.98M | 39.26M | 26.55M | 25.55M | 23.29M | 21.45M | 19.98M | 19.99M |
| Change in Working Capital | -19.70M | -61.85M | -25.86M | 16.75M | 7.19M | -76.26M | 25.41M | -5.66M | 24.20M | -55.46M | 10.84M | -14.52M |
| Operating Cash Flow | -88.83M | -222.74M | -247.60M | -219.76M | -205.57M | -262.09M | -195.98M | -180.92M | -122.95M | -184.03M | -130.82M | -136.33M |
| Capital Expenditures | -6.26M | -3.48M | -16.59M | -2.42M | -3.48M | -10.07M | -6.77M | -3.69M | -6.78M | -4.68M | -2.15M | -2.85M |
| Investing Cash Flow | 24.51M | 265.52M | 389.41M | -762.23M | 227.84M | 80.41M | 131.76M | -1.00B | -6.78M | 295.32M | 1.80M | 7.15M |
| Financing Cash Flow | 27.18M | 29.51M | 33.86M | 33.41M | 857.81M | 29.00M | 159.31M | 397.20M | 781.49M | 3.02M | 123.26M | 1.25M |
| Net Change in Cash | -37.42M | 71.74M | 175.68M | -949.56M | 881.08M | -151.78M | 93.58M | -785.35M | 651.07M | 113.36M | -4.74M | -125.77M |
| Free Cash Flow | -95.09M | -226.22M | -264.19M | -222.18M | -209.05M | -272.16M | -202.75M | -184.60M | -129.74M | -188.71M | -132.97M | -139.19M |
This table shows 12 quarterly periods of Insmed's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INSM's reporting calendar. What is a cash flow statement?